RecruitingNot ApplicableNCT05993832

Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures


Sponsor

Boston University Charles River Campus

Enrollment

40 participants

Start Date

Aug 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Mutual exclusivity is a word learning constraint in which the learner assumes that a given word refers to only one category of objects. In spoken languages, mutual exclusivity has been demonstrated in monolingual children as young as 17 months and cross-linguistically, while multilingual learners show an attenuated mutual exclusivity bias. Mutual exclusivity has not been robustly demonstrated in deaf children acquiring American Sign Language (ASL). Further, it is unclear if mutual exclusivity applies to those learning both a signed and a spoken language. Like unimodal bilinguals, bimodal bilingual (BiBi) children learn two words for an object, but these words are separated by modality. A BiBi child could therefore assume that all objects have two words (like unimodal bilinguals) or that all objects have one spoken word and one sign (within-modality mutual exclusivity). The goals of the current study are to demonstrate mutual exclusivity in monolingual deaf children acquiring ASL, and to determine if BiBi deaf children utilize mutual exclusivity within each modality.


Eligibility

Min Age: 18 MonthsMax Age: 60 Months

Inclusion Criteria5

  • Deaf children ages 18-60 months
  • born severely to profoundly deaf
  • have either deaf or hearing parents
  • communicate using American Sign Language
  • have normal to corrected normal vision

Exclusion Criteria1

  • Deaf children who have not been exposed to American Sign Language

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERinput cue

The object is labelled with 1) gaze only; 2) novel label only; or 3) conflicting gaze and novel label


Locations(1)

Boston University

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05993832


Related Trials